Hybio Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
129,930.70
171,561.70
305,342.00
291,924.70
329,721.40
340,779.30
Depreciation, Depletion & Amortization
15,046.10
33,591.10
86,551.20
94,805.50
100,416.50
100,853.80
Other Funds
18,922.90
14,500.00
436,804.10
627,247.10
51,929.80
593,806.10
Funds from Operations
143,565.10
218,321.90
431,944.50
474,891.90
504,231.10
339,396.40
Changes in Working Capital
9,910.80
64,896.00
293,104.00
177,940.10
290,247.40
292,134
Net Operating Cash Flow
153,475.90
153,425.90
138,840.50
296,951.80
213,983.80
47,262.40
Capital Expenditures
302,852.70
85,164.00
358,983.20
116,050.30
221,136.10
Sale of Fixed Assets & Businesses
-
-
156.30
184.00
57.60
Purchase/Sale of Investments
-
-
764,227.00
15,747.10
1,000.00
Net Investing Cash Flow
302,852.70
85,164.00
1,123,053.90
131,613.40
223,758.50
Cash Dividends Paid - Total
-
-
44,500.80
22,250.40
-
Issuance/Reduction of Debt, Net
-
198,600.00
74,500.00
80,528.30
356,107.10
Net Financing Cash Flow
18,922.90
184,100.00
466,803.30
524,468.40
408,037.00
Net Change in Cash
168,826.20
252,140.70
514,297.00
694,782.30
387,923.10
Free Cash Flow
149,376.80
68,261.90
220,142.70
180,901.50
7,152.40
Deferred Taxes & Investment Tax Credit
4,608.30
79.20
3,319.10
644.10
11,545.90
14,484.20
Exchange Rate Effect
526.40
221.20
3,113.20
4,975.50
10,339.20
Other Uses
-
-
-
-
1,680.00
About Hybio Pharmaceutical Co.
View Profile
